Literature DB >> 22592418

FGF23 and mineral metabolism, implications in CKD-MBD.

Mariano Rodríguez, Ignacio López, Juan Muñoz, Escolástico Aguilera-Tejero, Yolanda Almaden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22592418     DOI: 10.3265/Nefrologia.pre2012.Mar.11415

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


× No keyword cloud information.
  13 in total

1.  Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate.

Authors:  Emilio González-Parra; Álvaro Aceña; Óscar Lorenzo; Nieves Tarín; María Luisa González-Casaus; Carmen Cristóbal; Ana Huelmos; Ignacio Mahíllo-Fernández; Ana María Pello; Rocío Carda; Ignacio Hernández-González; Joaquín Alonso; Fernando Rodríguez-Artalejo; Lorenzo López-Bescós; Alberto Ortiz; Jesús Egido; José Tuñón
Journal:  J Bone Miner Metab       Date:  2015-08-23       Impact factor: 2.626

Review 2.  Recent developments in metabolic bone diseases: a gnathic perspective.

Authors:  Erich J Raubenheimer; Claudia E Noffke; Hilde D Hendrik
Journal:  Head Neck Pathol       Date:  2014-11-20

Review 3.  Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies.

Authors:  Mariano Rodríguez Portillo; María E Rodríguez-Ortiz
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

Review 4.  FGF23 associated bone diseases.

Authors:  Eryuan Liao
Journal:  Front Med       Date:  2013-03-09       Impact factor: 4.592

Review 5.  The Roles of Fibroblast Growth Factor (FGF)-23, α-Klotho and Furin Protease in Calcium and Phosphate Homeostasis : A Mini-Review.

Authors:  Roshan L Mattoo
Journal:  Indian J Clin Biochem       Date:  2013-04-09

6.  FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice.

Authors:  Ningyuan Sun; Yuchen Guo; Weiqing Liu; Michael Densmore; Victoria Shalhoub; Reinhold G Erben; Ling Ye; Beate Lanske; Quan Yuan
Journal:  Sci Rep       Date:  2015-02-10       Impact factor: 4.379

Review 7.  Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease⁻Metabolic Bone Disease (CKD-MBD).

Authors:  Mariano Rodriguez; Escolastico Aguilera-Tejero
Journal:  Nutrients       Date:  2018-12-01       Impact factor: 5.717

Review 8.  FGF23, Biomarker or Target?

Authors:  Cristian Rodelo-Haad; Rafael Santamaria; Juan R Muñoz-Castañeda; M Victoria Pendón-Ruiz de Mier; Alejandro Martin-Malo; Mariano Rodriguez
Journal:  Toxins (Basel)       Date:  2019-03-22       Impact factor: 4.546

Review 9.  FGF23 in Acute and Chronic Illness.

Authors:  Christian Schnedl; Astrid Fahrleitner-Pammer; Peter Pietschmann; Karin Amrein
Journal:  Dis Markers       Date:  2015-09-28       Impact factor: 3.434

10.  Phosphate control in reducing FGF23 levels in hemodialysis patients.

Authors:  Cristian Rodelo-Haad; Maria E Rodríguez-Ortiz; Alejandro Martin-Malo; M Victoria Pendon-Ruiz de Mier; M Luisa Agüera; Juan R Muñoz-Castañeda; Sagrario Soriano; Francisco Caravaca; M Antonia Alvarez-Lara; Arnold Felsenfeld; Pedro Aljama; Mariano Rodriguez
Journal:  PLoS One       Date:  2018-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.